A detailed history of Banco De Sabadell, S.A transactions in Sanofi stock. As of the latest transaction made, Banco De Sabadell, S.A holds 22,509 shares of SNY stock, worth $1.3 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
22,509
Previous 22,016 2.24%
Holding current value
$1.3 Million
Previous $1.07 Million 1.96%
% of portfolio
0.8%
Previous 0.8%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$45.39 - $50.36 $22,377 - $24,827
493 Added 2.24%
22,509 $1.09 Million
Q1 2024

May 13, 2024

BUY
$45.75 - $52.48 $101,793 - $116,768
2,225 Added 11.24%
22,016 $1.07 Million
Q4 2023

Feb 09, 2024

BUY
$43.13 - $54.79 $176,099 - $223,707
4,083 Added 25.99%
19,791 $985,000
Q3 2023

Nov 13, 2023

SELL
$50.95 - $55.2 $28,786 - $31,188
-565 Reduced 3.47%
15,708 $843,000
Q2 2023

Aug 14, 2023

SELL
$50.45 - $57.18 $4,288 - $4,860
-85 Reduced 0.52%
16,273 $877,000
Q1 2023

May 12, 2023

BUY
$45.86 - $54.45 $97,727 - $116,032
2,131 Added 14.98%
16,358 $888,000
Q4 2022

Feb 14, 2023

BUY
$38.86 - $48.55 $11,696 - $14,613
301 Added 2.16%
14,227 $689,000
Q3 2022

Nov 10, 2022

SELL
$37.22 - $100.5 $68,931 - $186,126
-1,852 Reduced 11.74%
13,926 $529,000
Q2 2022

Aug 11, 2022

SELL
$48.99 - $57.46 $21,114 - $24,765
-431 Reduced 2.66%
15,778 $788,000
Q1 2022

May 12, 2022

BUY
$48.48 - $53.65 $57,400 - $63,521
1,184 Added 7.88%
16,209 $833,000
Q4 2021

Feb 14, 2022

BUY
$47.07 - $52.35 $65,239 - $72,557
1,386 Added 10.16%
15,025 $754,000
Q3 2021

Nov 04, 2021

SELL
$47.89 - $53.12 $38,503 - $42,708
-804 Reduced 5.57%
13,639 $661,000
Q2 2021

Aug 13, 2021

SELL
$49.36 - $54.25 $3.36 Million - $3.69 Million
-67,991 Reduced 82.48%
14,443 $760,000
Q1 2021

May 14, 2021

SELL
$45.46 - $50.51 $2.37 Million - $2.63 Million
-52,141 Reduced 38.74%
82,434 $4.07 Million
Q4 2020

Feb 12, 2021

SELL
$45.3 - $51.62 $1.89 Million - $2.16 Million
-41,804 Reduced 23.7%
134,575 $6.52 Million
Q3 2020

Nov 13, 2020

BUY
$49.47 - $53.77 $134,954 - $146,684
2,728 Added 1.57%
176,379 $8.91 Million
Q2 2020

Aug 07, 2020

BUY
$42.91 - $52.5 $3.89 Million - $4.76 Million
90,654 Added 109.23%
173,651 $8.86 Million
Q1 2020

May 14, 2020

BUY
$38.02 - $51.66 $2.62 Million - $3.56 Million
68,936 Added 490.26%
82,997 $3.67 Million
Q4 2019

Feb 14, 2020

SELL
$44.25 - $50.86 $20,974 - $24,107
-474 Reduced 3.26%
14,061 $702,000
Q3 2019

Nov 15, 2019

SELL
$40.34 - $46.64 $13,392 - $15,484
-332 Reduced 2.23%
14,535 $673,000
Q2 2019

Aug 13, 2019

SELL
$40.43 - $44.3 $72,814 - $79,784
-1,801 Reduced 10.81%
14,867 $645,000
Q1 2019

May 14, 2019

SELL
$40.83 - $45.43 $125,756 - $139,924
-3,080 Reduced 15.6%
16,668 $737,000
Q4 2018

Feb 14, 2019

SELL
$41.48 - $45.59 $211,506 - $232,463
-5,099 Reduced 20.52%
19,748 $849,000
Q3 2018

Nov 16, 2018

SELL
$40.0 - $44.84 $15,520 - $17,397
-388 Reduced 1.54%
24,847 $1.11 Million
Q2 2018

Aug 15, 2018

SELL
$37.63 - $41.22 $1,279 - $1,401
-34 Reduced 0.13%
25,235 $1.01 Million
Q1 2018

May 16, 2018

BUY
$38.98 - $45.76 $266,584 - $312,952
6,839 Added 37.11%
25,269 $1.01 Million
Q4 2017

Feb 16, 2018

BUY
$42.86 - $50.61 $789,909 - $932,742
18,430
18,430 $792,000

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $145B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Banco De Sabadell, S.A Portfolio

Follow Banco De Sabadell, S.A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco De Sabadell, S.A, based on Form 13F filings with the SEC.

News

Stay updated on Banco De Sabadell, S.A with notifications on news.